SIG
Sargent Investment Group Portfolio holdings
AUM
$740M
1-Year Return
41.44%
This Quarter Return
+6.94%
1 Year Return
+41.44%
3 Year Return
+107.47%
5 Year Return
+182.16%
10 Year Return
–
AUM
$456M
AUM Growth
-$477K
(-0.1%)
Cap. Flow
-$24.3M
Cap. Flow
% of AUM
-5.33%
Top 10 Holdings %
Top 10 Hldgs %
39.08%
Holding
221
New
11
Increased
48
Reduced
122
Closed
20
Top Buys
| 1 |
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
|
$7.3M |
| 2 |
SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
|
$6.03M |
| 3 |
Microsoft
MSFT
|
$3.02M |
| 4 |
Mastercard
MA
|
$1.32M |
| 5 |
Walmart
WMT
|
$931K |
Top Sells
| 1 |
Janus Henderson AAA CLO ETF
JAAA
|
$4.83M |
| 2 |
Apple
AAPL
|
$3.73M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
$1.93M |
| 4 |
Palantir
PLTR
|
$1.55M |
| 5 |
Broadstone Net Lease
BNL
|
$1.34M |
Sector Composition
| 1 | Technology | 25.89% |
| 2 | Financials | 12.44% |
| 3 | Healthcare | 7.4% |
| 4 | Industrials | 6.67% |
| 5 | Consumer Discretionary | 4.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AY
176
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $247K | 0.05% |
13,340
-29,565
| -69% | -$546K |
|
177
Churchill Downs
CHDN
$7.15B
| $245K | 0.05% |
1,980
+10
| +0.5% | +$1.24K |
|
178
Pfizer
PFE
$140B
| $235K | 0.05% |
8,457
-6,982
| -45% | -$194K |
|
|
BFS
179
Saul Centers
BFS
$814M
| $232K | 0.05% |
6,025
| – | – |
|
180
O'Reilly Automotive
ORLY
$89.1B
| $229K | 0.05% |
+3,045
| New | +$229K |
|
181
Novo Nordisk
NVO
$249B
| $228K | 0.05% |
1,776
-1,000
| -36% | -$128K |
|
182
Progressive
PGR
$146B
| $224K | 0.05% |
+1,085
| New | +$224K |
|
183
Vanguard Total Stock Market ETF
VTI
$529B
| $224K | 0.05% |
860
| – | – |
|
184
Tootsie Roll Industries
TR
$2.95B
| $217K | 0.05% |
6,984
-210
| -3% | -$6.53K |
|
185
Dow Inc
DOW
$16.9B
| $213K | 0.05% |
3,685
-9,168
| -71% | -$531K |
|
186
United Parcel Service
UPS
$71.6B
| $210K | 0.05% |
1,416
-990
| -41% | -$147K |
|
187
STAG Industrial
STAG
$6.86B
| $208K | 0.05% |
5,422
-285
| -5% | -$11K |
|
188
Invesco S&P 500 Equal Weight ETF
RSP
$74B
| $207K | 0.05% |
+1,225
| New | +$207K |
|
189
Coca-Cola
KO
$294B
| $204K | 0.04% |
3,340
-62
| -2% | -$3.79K |
|
190
Rackspace Technology
RXT
$311M
| $182K | 0.04% |
+115,100
| New | +$182K |
|
191
Cohen & Steers Closed End Opportunity Fund
FOF
$362M
| $176K | 0.04% |
15,085
| – | – |
|
192
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $116K | 0.03% |
48,700
+22,640
| +87% | +$54.1K |
|
193
Relmada Therapeutics
RLMD
$45.5M
| $101K | 0.02% |
+21,818
| New | +$101K |
|
194
Novavax
NVAX
$1.27B
| $93.6K | 0.02% |
19,585
-760
| -4% | -$3.63K |
|
|
RVNC
195
DELISTED
Revance Therapeutics, Inc.
RVNC
| $63.4K | 0.01% |
12,895
-927
| -7% | -$4.56K |
|
196
Outset Medical
OM
$237M
| $58.1K | 0.01% |
1,745
-750
| -30% | -$25K |
|
197
Athira Pharma
ATHA
$15.3M
| $54.1K | 0.01% |
19,753
+1,549
| +9% | +$4.24K |
|
|
BLUE
198
DELISTED
bluebird bio
BLUE
| $49.9K | 0.01% |
1,951
+584
| +43% | +$14.9K |
|
199
Assertio
ASRT
$77.7M
| $43K | 0.01% |
44,864
| – | – |
|
200
Summit Therapeutics
SMMT
$17.7B
| $41.4K | 0.01% |
10,000
| – | – |
|